Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide used extensively in metabolic and endocrine research. This 39-amino acid synthetic peptide represents a significant advancement in incretin-based research compounds.

Key specifications:• Purity: 99% (HPLC verified)• Molecular Weight: 4813.5 Da• Form: Lyophilized powder• Storage: -20°C, protected from light

The dual-agonist mechanism allows researchers to study synergistic effects of GIP and GLP-1 receptor activation on glucose metabolism, insulin secretion, and appetite signaling pathways. Tirzepatide has become essential for comparative studies in metabolic research.

Includes Certificate of Analysis.